REGENXBIO reports Q3 2026 results, confirms Duchenne BLA and wet AMD data timelinesNov 5Quarterly updateREGENXBIO Inc.RGX-202
Regenxbio reports Q2 2026 results, cites Duchenne trial win and new AbbVie fundsAug 6Quarterly updateAbbVieREGENXBIO Inc.